FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.

J Immunother Cancer · 2021 · PMC8137193 · PMID 34006632

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

marginal significancep=0.050actually significant

Marginal significance was observed in the comparison between low-risk and high-risk groups (p=0.050), while no significant survival difference between moderate risk and low or high risk groups (p=0.644 and p=0.133, respectively).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.